On June 12 and 13, 2025, the 4th Dutch Antisense Therapeutics Symposium took place in Groningen (The Netherlands).
This meeting brought together more than 100 national and international participants working on antisense therapeutic strategies to treat rare diseases. This meeting also offers a platform to early career investigators to present their work and provides a friendly environment to network with the experts in the field.
Our Lifelong VISION PI Alex Garanto co-organized this year’s edition, which featured inspiring keynote lectures on entrepreneurship and regulatory pathways for translating antisense technologies into clinical applications either through conventional paths or n-of-1 personalized experimental treatments. The scientific program also highlighted exciting developments in novel delivery systems and therapeutic approaches targeting muscular, neurometabolic, and brain disorders amongst others. Edwin van Oosten, presented his work titled “Towards personalized antisense oligonucleotide treatment for Stargardt disease: targeting an ultrarare deep-intronic ABCA4 variant using human in vitro models” which was awarded with the 3rd prize for the best oral presentation.
The symposium showcased significant progress in delivery technologies and antisense therapeutics, reinforcing the growing impact of this field in addressing unmet medical needs.
The dates and location for next year will be released after summer on www.dutchantisense.org.
Related news items
First Summer School Brings Together Young Researchers for Two Inspiring Days
7 July 2026On Thursday 25 and Friday 26 June, we successfully hosted our first Summer School. Despite taking place during the hottest days of June, the enthusiasm and engagement of all participants made it a great success!
go to page
Making Science Visible
20 June 2026Award winning photograph by researcher Ivar Noordstra (Radboudumc) has attracted national attention. [ad.nl]
go to page
2nd Lifelong VISION Amsterdam seminar
28 May 2026On the 16th of April, the 2nd Lifelong Vision Amsterdam seminar brought our community together in a brisk afternoon of curiosity and collaboration.
go to page
Sensathon 2026 - Searching for answers together
13 April 2026On April 10th, Susanne Roosing, Rob Collin and Sterre Mulder of the LifeLong Vision consortium organized with Mechteld van Olden and Dirk Wijn the Sensathon, during the Hearing & Vision 4 All research program day at Radboudumc.
go to page
Breakthrough in Research on Inherited Blindness!
12 January 2026Researchers at Radboudumc have discovered a new genetic cause of retinitis pigmentosa (RP) — an eye disease affecting about 1 in 5,000 people worldwide, often leading to tunnel vision and eventually complete blindness.
go to pageZohreh Hosseinzadeh at BMPN Annual meeting
24 November 2025At the BMPN Annual meeting Zohreh Hosseinzadeh presented Lifelong Vision as an example of promoting collaboration between clinical practice and scientific research.
go to page